CytomX Therapeutics, Inc (CTMX) insider trading
Every open-market stock purchase and sale by CytomX Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Sean A. McCarthy (CEO) sold $462K in the last 90 days.
- Last insider buy: Elaine V Jones (Insider), $7.8K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $2.2M (7 sales). Last close $2.40 on Oct 21, 2026.
Recent CTMX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 3, 2026 | Alejandra Carvajal (C-suite exec) | Bought (not open market) | — |
| Aug 3, 2026 | Alejandra Carvajal (C-suite exec) | Bought (not open market) | — |
| Jul 24, 2026 | Charles S. Fuchs (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Halley E Gilbert (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | James R Meyers (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Matthew P. Young (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Zhen Su (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Mani Mohindru (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Alan Ashworth (Insider) | Bought (not open market) | — |
| Jun 17, 2026 | Elaine V Jones (Insider) | Bought (not open market) | — |
| Jun 15, 2026 | Christopher Ogden (CFO) | Sold | $5K |
| Mar 17, 2026 | Sean A. McCarthy (CEO) | Sold | $764K |
| Mar 17, 2026 | Marcia Belvin (C-suite exec) | Sold | $202K |
| Mar 17, 2026 | Yu-Waye Chu (C-suite exec) | Sold | $137K |
| Mar 17, 2026 | Christopher Ogden (CFO) | Sold | $124K |
| Feb 2, 2026 | Sean A. McCarthy (CEO) | Bought (not open market) | — |
| Feb 2, 2026 | Marcia Belvin (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Marcia Belvin (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Yu-Waye Chu (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Yu-Waye Chu (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Sean A. McCarthy (CEO) | Bought (not open market) | — |
| Feb 2, 2026 | Christopher Ogden (CFO) | Bought (not open market) | — |
| Feb 2, 2026 | Rachael Lester (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Rachael Lester (C-suite exec) | Bought (not open market) | — |
| Feb 2, 2026 | Christopher Ogden (CFO) | Bought (not open market) | — |
Who's trading CTMX
- Alejandra Carvajal, C-suite exec: other filings, last Aug 3, 2026
- Charles S. Fuchs, Insider: other filings, last Jul 24, 2026
- Alan Ashworth, Insider: other filings, last Jun 17, 2026
- Halley E Gilbert, Insider: other filings, last Jun 17, 2026
- Elaine V Jones, Insider: other filings, last Jun 17, 2026
- James R Meyers, Insider: other filings, last Jun 17, 2026
- Mani Mohindru, Insider: other filings, last Jun 17, 2026
- Zhen Su, Insider: other filings, last Jun 17, 2026
- Matthew P. Young, Insider: other filings, last Jun 17, 2026
- Christopher Ogden, CFO: sold $129K (2 sales), last Jun 15, 2026
- Yu-Waye Chu, C-suite exec: sold $137K (1 sale), last Mar 17, 2026
- Marcia Belvin, C-suite exec: sold $202K (1 sale), last Mar 17, 2026
- Sean A. McCarthy, CEO: sold $1.7M (3 sales), last Mar 17, 2026
- Rachael Lester, C-suite exec: other filings, last Feb 2, 2026
Get free alerts when an insider at CytomX Therapeutics, Inc files a new trade →